Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · Jul 2, 2026, 5:28 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Delineate Official company site.
Raised $500K across 1 funding round. Latest: $500K Seed (Apr 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Seed (Apr 2025). Investors: Y Combinator. (High).
Product / news
Limited product/news coverage in corpus (Low).
Verified facts
Winter 2025 batch; AI agents for accelerated clinical trial design.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:00 PM · confidence 88%high quality
wikipedia · Mon, Jun 29, 05:24 AM · confidence 50%low quality
wikipedia · Mon, Jun 29, 05:24 AM · confidence 50%low quality
Newest first · 6 event(s)
Source: official_site
Delineate — Quantitative evidence for consequential decisions
Winter 2025 batch; AI agents for accelerated clinical trial design.
Source: wikipedia
2 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Delineate — Quantitative evidence for consequential decisions
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Official company site.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗2 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
Winter 2025 batch; AI agents for accelerated clinical trial design.
Why it matters: Funding signal — Seed per this source; verify against the linked original before relying on it.
Open source ↗1 row(s)
Public engineering activity. Sustained commits, releases, and stars indicate real product development and, for dev tools, developer adoption.
An R-Tree partition algorithm.
Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.